Preoperative chemoradiotherapy in locally advanced rectal cancer: correlation of a gene expression-based response signature with recurrence

Cancer Genetics and Cytogenetics

Volumn 190, Issue 2, 2009, Pages 57-65

  Liersch, Torsten ^a   Grade, Marian ^a,b   Gaedcke, Jochen ^a   Varma, Sudhir ^b   Difilippantonio, Michael J ^b   Langer, Claus ^a   Hess, Clemens F ^c   Becker, Heinz ^a   Ried, Thomas ^b   Ghadimi, B Michael ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; PERITONEUM METASTASIS; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECTUM CANCER; RECTUM CARCINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR GENE;

AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 64549147055     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.11.011     Document Type: Article

References (47)

1. Alon U., Barkai N., Notterman D.A., Gish K., Ybarra S., Mack D., and Levine A.J. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci U S A 96 (1999) 6745-6750
2. Notterman D.A., Alon U., Sierk A.J., and Levine A.J. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61 (2001) 3124-3130
3. Kitahara O., Furukawa Y., Tanaka T., Kihara C., Ono K., Yanagawa R., Nita M.E., Takagi T., Nakamura Y., and Tsunoda T. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res 61 (2001) 3544-3549
4. Zou T.T., Selaru F.M., Xu Y., Shustova V., Yin J., Mori Y., Shibata D., Sato F., Wang S., Olaru A., Deacu E., Liu T.C., Abraham J.M., and Meltzer S.J. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 21 (2002) 4855-4862
5. Lechner S., Müller-Ladner U., Renke B., Schölmerich J., Rüschoff J., and Kullmann F. Gene expression pattern of laser microdissected colonic crypts of adenomas with low grade dysplasia. Gut 52 (2003) 1148-1153
6. Sugiyama Y., Farrow B., Murillo C., Li J., Watanabe H., Sugiyama K., and Evers B.M. Analysis of differential gene expression patterns in colon cancer and cancer stroma using microdissected tissues. Gastroenterology 128 (2005) 480-486
7. Grade M., Ghadimi B.M., Varma S., Simon R., Wangsa D., Barenboim-Stapleton L., Liersch T., Becker H., Ried T., and Difilippantonio M.J. Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/β-catenin signaling pathway in human rectal carcinomas. Cancer Res 66 (2006) 267-282
8. Kwon H.C., Kim S.H., Roh M.S., Kim J.S., Lee H.S., Choi H.J., Jeong J.S., Kim H.J., and Hwang T.H. Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer. Dis Colon Rectum 47 (2004) 141-152
9. Koehler A., Bataille F., Schmid C., Ruemmele P., Waldeck A., Blaszyk H., Hartmann A., Hofstaedter F., and Dietmaier W. Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage. J Pathol 204 (2004) 65-74
10. Croner R.S., Peters A., Brueckl W.M., Matzel K.E., Klein-Hitpass L., Brabletz T., Papadopoulos T., Hohenberger W., Reingruber B., and Lausen B. Microarray versus conventional prediction of lymph node metastasis in colorectal carcinoma. Cancer 104 (2005) 395-404
11. D'Arrigo A., Belluco C., Ambrosi A., Digito M., Esposito G., Bertola A., Fabris M., Nofrate V., Mammano E., Leon A., Nitti D., and Lise M. Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma. Int J Cancer 115 (2005) 256-262
12. Grade M., Hörmann P., Becker S., Hummon A.B., Wangsa D., Varma S., Simon R., Liersch T., Becker H., Difilippantonio M.J., Ghadimi B.M., and Ried T. Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. Cancer Res 67 (2007) 41-56
13. Wang Y., Jatkoe T., Zhang Y., Mutch M.G., Talantov D., Jiang J., McLeod H.L., and Atkins D. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 22 (2004) 1564-1571
14. Arango D., Laiho P., Kokko A., Alhopuro P., Sammalkorpi H., Salovaara R., Nicorici D., Hautaniemi S., Alazzouzi H., Mecklin J.P., Järvinen H., Hemminki A., Astola J., Schwartz Jr. S., and Aaltonen L.A. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. Gastroenterology 129 (2005) 874-884
15. Eschrich S., Yang I., Bloom G., Kwong K.Y., Boulware D., Cantor A., Coppola D., Kruhøffer M., Aaltonen L., Orntoft T.F., Quackenbush J., and Yeatman T.J. Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 23 (2005) 3526-3535
16. Barrier A., Boelle P.Y., Roser F., Gregg J., Tse C., Brault D., Lacaine F., Houry S., Huguier M., Franc B., Flahault A., Lemoine A., and Dudoit S. Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol 24 (2006) 4685-4691
17. Barrier A., Roser F., Boëlle P.Y., Franc B., Tse C., Brault D., Lacaine F., Houry S., Callard P., Penna C., Debuire B., Flahault A., Dudoit S., and Lemoine A. Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling. Oncogene 26 (2007) 2642-2648
18. Lin Y.H., Friederichs J., Black M.A., Mages J., Rosenberg R., Guilford P.J., Phillips V., Thompson-Fawcett M., Kasabov N., Toro T., Merrie A.E., van Rij A., Yoon H.S., McCall J.L., Siewert J.R., Holzmann B., and Reeve A.E. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer. Clin Cancer Res 13 (2007) 498-507
19. Mariadason J.M., Arango D., Shi Q., et al. Gene expression profiling-based prediction of response of colon carcinoma cells Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res 63 (2003) 8791-8812
20. Del Rio M., Molina F., Bascoul-Mollevi C., Copois V., Bibeau F., Chalbos P., Bareil C., Kramar A., Salvetat N., Fraslon C., Conseiller E., Granci V., Leblanc B., Pau B., Martineau P., and Ychou M. Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan. J Clin Oncol 25 (2007) 773-780
21. Smith F.M., Reynolds J.V., Miller N., Stephens R.B., and Kennedy M.J. Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy. Eur J Surg Oncol 32 (2006) 55-64
22. Sauer R., Becker H., Hohenberger W., Rödel C., Wittekind C., Fietkau R., Martus P., Tschmelitsch J., Hager E., Hess C.F., Karstens J.H., Liersch T., Schmidberger H., Raab R., and German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
23. Kachnic L.A. Should preoperative or postoperative therapy be administered in the management of rectal cancer?. Semin Oncol 33 6 Suppl. 11 (2006) S64-S69
24. Rödel C., Martus P., Papadoupolos T., Füzesi L., Klimpfinger M., Fietkau R., Liersch T., Hohenberger W., Raab R., Sauer R., and Wittekind C. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23 (2005) 8688-8696
25. Ghadimi B.M., Grade M., Difilippantonio M.J., Varma S., Simon R., Montagna C., Füzesi L., Langer C., Becker H., Liersch T., and Ried T. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 23 (2005) 1826-1838
26. Heald R.J., and Ryall R.D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1 8496 (1986) 1479-1482
27. Sobin L.H., and Wittekind C. International Union Against Cancer (UICC). TNM classification of malignant tumours. 5th ed. (1997), Wiley-Liss, New York
28. Quirke P., Durdey P., Dixon M.F., and Williams N.S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet 2 8514 (1986) 996-999
29. Quirke P., and Dixon M.F. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis 3 (1988) 127-131
30. Liersch T., Langer C., Jakob C., Müller D., Ghadimi B.M., Siemer A., Markus P.M., Füzesi L., and Becker H. Preoperative diagnostic procedures in locally advanced rectal carcinoma (≥T3 or N+). What does endoluminal ultrasound achieve at staging and restaging (after neoadjuvant radiochemotherapy) in contrast to computed tomography? [In German]. Chirurg 74 (2003) 224-234
31. Liersch T., Langer C., Ghadimi B.M., Kulle B., Aust D.E., Baretton G.B., Schwabe W., Häusler P., Becker H., and Jakob C. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy. J Clin Oncol 24 (2006) 4062-4068
32. Simon R., and Peng A. BRB ArrayTools. Version 3.5.0 ed (2007), National Cancer Institute, Bethesda
33. Wright G.W., and Simon R.M. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19 (2003) 2448-2455
34. Bosset J.F., Collette L., Calais G., Mineur L., Maingon P., Radosevic-Jelic L., Daban A., Bardet E., Beny A., and Ollier J.C. EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123 [Erratum in: N Engl J Med 2007;357:728]
35. Gérard J.P., Conroy T., Bonnetain F., Bouché O., Chapet O., Closon-Dejardin M.T., Untereiner M., Leduc B., Francois E., Maurel J., Seitz J.F., Buecher B., Mackiewicz R., Ducreux M., and Bedenne L. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24 (2006) 4620-4625
36. Rayala S.K., and Kumar R. Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity. Biomed Pharmacother 61 (2007) 408-411
37. Bostner J., Ahnström Waltersson M., Fornander T., Skoog L., Nordenskjöld B., and Stål O. Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer. Oncogene 26 (2007) 6997-7005
38. O'Sullivan G.C., Tangney M., Casey G., Ambrose M., Houston A., and Barry O.P. Modulation of p21-activated kinase 1 alters the behavior of renal cell carcinoma. Int J Cancer 121 (2007) 1930-1940
39. Krivtsov A.V., and Armstrong S.A. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 7 (2007) 823-833
40. Nakamura T., Canaani E., and Croce C.M. Oncogenic All1 fusion proteins target Drosha-mediated microRNA processing. Proc Natl Acad Sci U S A 104 (2007) 10980-10985
41. Grasberger H., and Bell G.I. Subcellular recruitment by TSG118 and TSPYL implicates a role for zinc finger protein 106 in a novel developmental pathway. Int J Biochem Cell Biol 37 (2005) 1421-1437
42. Ong L.L., Er C.P., Ho A., Aung M.T., and Yu H. Kinectin anchors the translation elongation factor-1δ to the endoplasmic reticulum. J Biol Chem 278 (2003) 32115-32123
43. Ong L.L., Lin P.C., Zhang X., Chia S.M., and Yu H. Kinectin-dependent assembly of translation elongation factor-1 complex on endoplasmic reticulum regulates protein synthesis. J Biol Chem 281 (2006) 33621-33634
44. Fortes P., Longman D., McCracken S., Ip J.Y., Poot R., Mattaj I.W., Cáceres J.F., and Blencowe B.J. Identification and characterization of RED120: a conserved PWI domain protein with links to splicing and 3′-end formation. FEBS Lett 581 (2007) 3087-3097
45. Nishimura N., Plutner H., Hahn K., and Balch W.E. The δ subunit of AP-3 is required for efficient transport of VSV-G from the trans-Golgi network to the cell surface. Proc Natl Acad Sci U S A 99 (2002) 6755-6760
46. Kim Y.M., Watanabe T., Allen P.B., Kim Y.M., Lee S.J., Greengard P., Nairn A.C., and Kwon Y.G. PNUTS, a protein phosphatase 1 (PP1) nuclear targeting subunit: characterization of its PP1- and RNA-binding domains and regulation by phosphorylation. J Biol Chem 278 (2003) 13819-13828
47. Simon R. New challenges for 21st century clinical trials. Clin Trials 4 (2007) 167-169 discussion 173-7